In an embryonic mouse torso, researches closely track how the parallel paths of blood vessels (gray) and nerve cells (red) develop. Understanding such processes is critical to studying birth defects and other developmental disorders. (credit: Shachi Bhatt and Paul Trainor/Stowers Institute for Medical Research)
This year’s winners of the BioArt competition, put on by Federation of American Societies for Experimental Biology (FASEB), pay equal respect to the colorful and dark sides of life. From awe-inspiring intricacies of nerve cell development and brain connectivity to the molecular machinery of the Ebola virus and mobility of cancer cells, the full spectrum of life is represented.
Shachi Bhatt and Paul Trainor/Stowers Institute for Medical Research
In an embryonic mouse torso, researches closely track how the parallel paths of blood vessels (gray) and nerve cells (red) develop. Understanding such processes is critical to studying birth defects and other developmental disorders.
11 more images in gallery
The contest, in its fourth year, is aimed at showcasing the artistic side of the day-to-day happenings of biomedical research. In a news release, FASEB President Parker Antin noted that “although the winning entries illustrate only a small segment of research being done across the country, they demonstrate how fascinating and beautiful biological science can be.”
Testing out a confetti-colored tracking method for cancer cells, researchers snap a shot of pancreatic cancer cells in a mouse model. The cancer cells are given colored markers that can signify a tissue or organ of origin, helping researchers track how tumor cells spread through the body. (credit: Heinz Baumann, Sean T. Glenn, Mary Kay Ellsworth, and Kenneth W. Gross/Roswell Park Cancer Institute, Buffalo, NY)
This year, the contest also honored two videos. The first (below) captured bacteria blooming on an agar plate over the course of weeks. The bacteria include Serratia (red), Bacillus (white), and Nesterenkonia (yellow).
Read 1 remaining paragraphs | Comments
No comments:
Post a Comment